Jaguar Health Inc (JAGX) |
|
2.92 -0.35 (-10.7%)
|
01-21 00:50 |
|
Open: |
3.1038 |
Pre. Close: |
3.27 |
|
High:
|
3.13 |
Low:
|
2.8 |
|
Volume:
|
26,059,118 |
Market Cap:
|
344M |
|
|
|
|
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. The company is headquartered in San Francisco, California and currently employs 17 full-time employees. The firm is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc., is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Its Mytesi is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with human immunodeficiency virus HIV/ acquired immune deficiency syndrome (AIDS) on antiretroviral therapy. Its other products include Canalevia, Equilevia, Neonorm Calf and Neonorm Foal. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.135 - 3.157 |
3.157 - 3.173 |
|
Low:
|
2.747 - 2.775 |
2.775 - 2.796 |
|
Close:
|
2.881 - 2.919 |
2.919 - 2.948 |
|
Technical analysis |
as of: 2021-01-20 4:48:57 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 5.22 One year: 6.10 |
| Support: |
Support1: 1.91 Support2: 0.32 |
| Resistance: |
Resistance1: 4.47 Resistance2: 5.22 |
| Pivot: |
2.54  |
| Moving Average: |
MA(5): 3.30  MA(20): 2.07
MA(100): 0.66 MA(250): 0.60 |
| MACD: |
MACD(12,26): 0.76 Signal(9): 0.69 |
| Stochastic oscillator: |
%K(14,3): 65.73 %D(3): 69.57 |
| RSI: |
RSI(14): 63.74 |
| 52-week: |
High: 4.47 Low: 0.19 Change(%): 262.7 |
| Average Vol(K): |
3-Month: 5932403 10-Days: 7956943 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.JAGX has closed below upper band by 41.4%. Bollinger Bands are 587.5% wider than normal. The large width of the bands suggest high volatility as compared to JAGX's normal range. The bands have been in this wide range for 17 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Wed, 20 Jan 2021
Jaguar Health Announces Closing of $6.0 Million Issuance and Sale of Designation-backed Note Related to Possible Tropical Disease Priority Review Voucher - Yahoo Finance
Fri, 15 Jan 2021
Jaguar Health Provides Replay Link & High-level Overview of January 14th Investor Webcast - Yahoo Finance
Thu, 14 Jan 2021
Jaguar Health Inc (JAGX) Stock: Buy, Hold, or Sell? - InvestorsObserver
Wed, 13 Jan 2021
Jaguar Health Announces $15 Million Registered Direct Offering Priced Above-the-Market Under Nasdaq Rules - Yahoo Finance
Tue, 12 Jan 2021
Jaguar Health to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference the Week of January 11th and at 4:30 pm Eastern on Tuesday, January 19th at the NobleCon17 Virtual Conference - Yahoo Finance
Tue, 12 Jan 2021
Don't Try to Tame Jaguar Health Stock As It Rips Higher - InvestorPlace
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
107 |
| Shares Float (M) |
63 |
|
% Held by Insiders
|
8.01 |
|
% Held by Institutions
|
6.70 |
|
Shares Short (K)
|
2,310 |
|
Shares Short P. Month (K)
|
429 |
Stock Financials |
|
EPS
|
-1.551 |
|
EPS Est This Year
|
-0.680 |
|
EPS Est Next Year
|
-0.220 |
|
Book Value (p.s.)
|
0.040 |
|
Profit Margin
|
|
|
Operating Margin
|
-266.17 |
|
Return on Assets (ttm)
|
-38.5 |
|
Return on Equity (ttm)
|
-220.0 |
|
Qtrly Rev. Growth
|
185.0 |
|
Gross Profit (p.s.)
|
-0.035 |
|
Sales Per Share
|
0.078 |
|
EBITDA (p.s.)
|
-0.190 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-14 |
|
Levered Free Cash Flow (M)
|
-1 |
Stock Valuations |
|
PE Ratio
|
-1.88 |
|
PEG Ratio
|
|
|
Price to Book value
|
73.00 |
|
Price to Sales
|
37.67 |
|
Price to Cash Flow
|
-21.83 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
